Abu Dhabi – Mubasher: Burjeel Holdings generated net profits standing at AED 361.77 million in the first nine months (9M) of 2023, marking a 76.40% hike from AED 205.07 million in 9M-22.
The ADX-listed firm posted revenues valued at AED 3.31 billion in the January-September 2023 period, an annual rise of 17.20% from AED 2.83 billion, according to the income statements.
Basic and diluted earnings per share (EPS) attributable to the shareholders increased to AED 0.07 in 9M-23 from AED 0.04 a year earlier.
Total assets amounted to AED 4.94 billion in 9M-23, versus AED 4.68 billion as of 31 December 2022.
Financial Results for Q3-23
In the third quarter (Q3) of 2023, the company recorded a 162.60% year-on-year (YoY) leap in net profit to AED 137.05 million, compared to AED 52.19 million.
Total revenues grew by 23.80% to AED 1.55 billion in Q3-23 from AED 933.15 million in Q3-22, while the basic and diluted EPS went up to AED 0.02 from AED 0.01.
John Sunil, CEO of Burjeel Holdings, said: "Burjeel Holdings delivered another strong set of results during Q3-23, as we focused on executing our strategy to drive patient yields through the provision of highly specialized complex care delivered by world-class medical professionals as we further ramped up our growth assets.”
This enabled us to accelerate our growth trajectory with Group revenue increasing 23.80% and EBITDA growing by an impressive 34.10% in the third quarter of 2023, driven by both an increase in patient footfall and the expansion of our complex care offering.
“Our international expansion continues at pace with the opening of our first four PhysioTherabia centres in Saudi Arabia. With ambitious growth plans to open 60 centers by 2025, PhysioTherabia marks the first step of our KSA journey.
During January-June 2023, Burjeel registered net profits attributable to the shareholders worth AED 213.68 million, higher by 47% YoY than AED 143.30 million.
